Hospital Acquired Infections Therapeutic market

Hospital Acquired Infections Therapeutic Market, Global Outlook and Forecast 2022-2028

  • 30 April 2022
  • Life Sciences
  • 69 Pages
  • Report code : PMR-7028611

  • 4.7 (158)

Hospital Acquired Infections Therapeutic Market

Download FREE Report Sample

  Download Free sample

A?hospital-acquired infection?(HAI) is an?infection?whose development is favoured by a?hospital?environment, such as one?acquired?by a patient during a?hospital?visit. The most common types are bloodstream infection (BSI), pneumonia (eg, ventilator-associated pneumonia [VAP]), urinary tract infection (UTI), and surgical site infection (SSI). Antifungal therapy (eg, fluconazole, caspofungin, voriconazole, amphotericin B) in some cases are added to empiric antibiotic coverage. Antiviral therapy (eg, ganciclovir, acyclovir) can be used in the treatment of suspected disseminated viral infections.

Hospital Acquired Infections Therapeutic Market contains market size and forecasts of Hospital Acquired Infections Therapeutic in Global, including the following market information:

Global Hospital Acquired Infections Therapeutic Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Hospital Acquired Infections Therapeutic market was valued at 9774.4 million in 2021 and is projected to reach US$ 12880 million by 2028, at a CAGR of 4.0% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Antibacterial Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Hospital Acquired Infections Therapeutic include Merck, Pfizer, Bayer, GlaxoSmithKline, Daiichi Sankyo, AbbVie, Abbott Laboratories, Roche and Jiangsu Hengrui Medicine and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Hospital Acquired Infections Therapeutic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hospital Acquired Infections Therapeutic Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Hospital Acquired Infections Therapeutic Market Segment Percentages, by Type, 2021 (%)

Antibacterial Drugs

Antiviral Drugs

Antifungal Drugs

Global Hospital Acquired Infections Therapeutic Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Hospital Acquired Infections Therapeutic Market Segment Percentages, by Application, 2021 (%)

Urinary Tract Infections

Ventilator-associated Pneumonia

Surgical Site Infections

Bloodstream Infections

Other Hospital Infections

Global Hospital Acquired Infections Therapeutic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Hospital Acquired Infections Therapeutic Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Hospital Acquired Infections Therapeutic revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Hospital Acquired Infections Therapeutic revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Merck

Pfizer

Bayer

GlaxoSmithKline

Daiichi Sankyo

AbbVie

Abbott Laboratories

Roche

Jiangsu Hengrui Medicine

Eli Lilly

CHECK TODAYS BEST PRICE

BEST PRICE: $2275
Buy Full Report

Select Licence type with your requirement and needs

SECURITY ASSUREDpayment image

analyst icon
Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research


Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

WHY CHOOSE US

  • Proactive We manage our resources 24/7 to identify issues and address them before they become problems
  • Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
  • Global Outreach 6 Major regions and 40+ countries level analysis accomplished
  • Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

SOME OF OUR CLIENTS
WHAT SET US APART?
  • quilty

    Quality Assurance

    Focus on Data Accuracy & Reliability
  • quilty

    Trusted by the Best

    75+ Clients in Fortune 500
  • quilty

    Privacy and Security

    All your transactions are secured end-to-end, ensuring a satisfactory purchase
  • quilty

    Competitive Pricing

    Ensure the best and affordable pricing
OUR HAPPY CUSTOMER Some of our customer review
Stay Updated About Hospital Acquired Infections Therapeutic Market

Leave This Empty: